Enanta Pharmaceuticals Inc
NASDAQ:ENTA

Watchlist Manager
Enanta Pharmaceuticals Inc Logo
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Watchlist
Price: 14.42 USD -8.56%
Market Cap: 416.2m USD

Relative Value

The Relative Value of one ENTA stock under the Base Case scenario is 10.88 USD. Compared to the current market price of 14.42 USD, Enanta Pharmaceuticals Inc is Overvalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ENTA Relative Value
Base Case
10.88 USD
Overvaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
78
Median 3Y
5
Median 5Y
7.7
Industry
8
Forward
6.3
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-5.6
Industry
23.5
Forward
-4.6
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-12.5
Industry
21.9
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-6.8
Industry
24.3
vs History
1
vs Industry
57
Median 3Y
2.5
Median 5Y
3.1
Industry
3.2
vs History
50
vs Industry
85
Median 3Y
1.9
Median 5Y
5.8
Industry
8.1
Forward
5.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
20
Median 3Y
-1.2
Median 5Y
-4.7
Industry
5.9
Forward
-4.6
vs History
vs Industry
18
Median 3Y
-1.2
Median 5Y
-4.4
Industry
6.2
Forward
-3.8
vs History
vs Industry
21
Median 3Y
-1.8
Median 5Y
-10.1
Industry
7.7
vs History
vs Industry
18
Median 3Y
-1.4
Median 5Y
-8.6
Industry
6.3
vs History
50
vs Industry
71
Median 3Y
1.3
Median 5Y
4.2
Industry
5.6

Multiples Across Competitors

ENTA Competitors Multiples
Enanta Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
416.2m USD 6.4 -5.1 -4.2 -4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
388.8B USD 6.5 165.6 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172.1B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
145.5B USD 5 17.9 12 12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.2B USD 9.7 30.8 22.6 23.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD 5.6 17.5 16.7 18.9
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.3 159.1 193
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.3 33.7 58.1 59.7
P/E Multiple
Earnings Growth PEG
US
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Average P/E: 186.1
Negative Multiple: -5.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
17.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
10%
1.7
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.3
N/A N/A
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Average EV/EBITDA: 39.4
Negative Multiple: -4.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.6
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Average EV/EBIT: 45.4
Negative Multiple: -4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
193
N/A N/A
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A